Transforming prostate cancer diagnosis: Feasibility testing of a novel system for integrated endorectal MRI and in-bore biopsy

STTR Phase Phase I award: "Transforming prostate cancer diagnosis: Feasibility testing of a novel system for integrated endorectal MRI and in-bore biopsy" awarded to Omnecoil Instruments, Inc. in Lake Oswego, Oregon. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $399,995. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.